Core Insights - Tianchen Medical (688013) reported a significant increase in revenue and net profit for the first three quarters of 2025, indicating strong financial performance driven by innovation and cost optimization [1][2]. Financial Performance - The company achieved operating revenue of 243,831,328.07 yuan, representing a year-on-year growth of 20.66% [1]. - Net profit attributable to shareholders reached 71,945,750.36 yuan, marking a substantial increase of 68.29% compared to the previous year [1]. - The net cash flow from operating activities was 63,784,159.86 yuan, up by 65.58% year-on-year [1]. Strategic Initiatives - Profit growth is attributed to the company's commitment to an innovation-driven strategy and a dual domestic and international market approach, leading to increased product volume and improved gross margin by 5.02 percentage points [1]. Asset and Equity Growth - Total assets amounted to 676,021,270.25 yuan, reflecting a growth of 6.09% from the end of the previous year [1]. - Shareholders' equity attributable to the parent company was 599,615,312.18 yuan, which is a 3.13% increase from the previous year-end [1]. Shareholder Information - As of the report date, the total number of ordinary shareholders was 4,624, with the top two shareholders, Chen Wangyu and Chen Wangdong, holding 25.85% and 25.79% of the shares, respectively, acting as controlling shareholders [2].

Core Insights - Tianchen Medical reported a revenue of 87,663,076.62 yuan for Q3 2025, representing a year-on-year growth of 26.40% [2] - The net profit attributable to shareholders of the listed company was 23,734,176.27 yuan, showing a significant increase of 70.74% compared to the previous year [2] Financial Performance - Revenue for Q3 2025: 87.66 million yuan, up 26.40% year-on-year [2] - Net profit for Q3 2025: 23.73 million yuan, up 70.74% year-on-year [2]

Growth - Yian Technology reported a net profit of 19.03 million yuan in Q3, a year-on-year increase of 10,957% [1] - Hwa Woo Co. achieved a net profit of 24.32 million yuan in Q3, up 4,202% year-on-year [1] - Zhuoyi Information's Q3 net profit reached 17.48 million yuan, reflecting a year-on-year growth of 2,074.65% [1] - Jingrui Electric Materials reported a net profit of 58.61 million yuan in Q3, marking a 938.99% increase year-on-year [1] - Hemei Group's Q3 net profit was 61.75 million yuan, up 706.3% year-on-year [1] - Kelin Electric's Q3 net profit was 56.52 million yuan, a year-on-year increase of 705.48% [1] - Hualu Biological's Q3 net profit reached 70.03 million yuan, reflecting a 619.37% year-on-year growth [1] - Triangle Defense reported a net profit of 105 million yuan in Q3, up 466.32% year-on-year [1] - New Meixing achieved a Q3 net profit of 38.44 million yuan, a year-on-year increase of 357.83% [1] - Hailanxin's Q3 net profit was 5.67 million yuan, reflecting a 342.12% year-on-year growth [1] - Zhenlei Technology reported a net profit of 38.64 million yuan in Q3, up 337.49% year-on-year [1] - Tovey Information's Q3 net profit reached 26.04 million yuan, a year-on-year increase of 239.19% [1] - Wanma Co. reported a net profit of 161 million yuan in Q3, reflecting a 227.70% year-on-year growth [1] - Juhua Co. achieved a Q3 net profit of 1.197 billion yuan, up 186.55% year-on-year [1] - Baofeng Energy reported a net profit of 3.232 billion yuan in Q3, marking a 162.34% increase year-on-year [1] - Sanfu Co. achieved a Q3 net profit of 25.68 million yuan, reflecting a 162.25% year-on-year growth [1] - Chuling Information's Q3 net profit was 248.72 million yuan, up 123.93% year-on-year [1] - Fujilai reported a net profit of 30.32 million yuan in Q3, a year-on-year increase of 113.62% [1] - San Sheng Guojian achieved a Q3 net profit of 209 million yuan, reflecting a 101.41% year-on-year growth [1] - Tianchen Medical reported a net profit of 23.73 million yuan in Q3, up 70.74% year-on-year [1] - Oke Yi's Q3 net profit was 50.35 million yuan, reflecting a 69.31% year-on-year growth [1] - Dingtai High-tech reported a net profit of 123 million yuan in Q3, up 47.05% year-on-year [1] - Yiwei Lithium Energy achieved a Q3 net profit of 1.211 billion yuan, reflecting a 15.13% year-on-year growth [1] - Anpeilong reported a net profit of 30.99 million yuan in Q3, up 14.09% year-on-year [1] - Shengtun Mining's Q3 net profit was 649 million yuan, reflecting an 11.32% year-on-year growth [1] - COSCO Shipping Special reported a net profit of 504 million yuan in Q3, up 6.62% year-on-year [1] - Deep Technology achieved a Q3 net profit of 41.45 million yuan, reflecting a 2.8% year-on-year growth [1] Decline and Loss - Qiaqia Food reported a Q3 net profit of 79.36 million yuan, a year-on-year decrease of 72.58% [2] - Ningbo Jingda's Q3 net profit was 10.83 million yuan, down 65.14% year-on-year [2] - Nanhua Futures reported a Q3 net profit of 120 million yuan, reflecting a year-on-year decline of 6.21% [2] - Zhongwen Online reported a Q3 net loss of 294 million yuan [2] - Tuolisi reported a Q3 net loss of 86.45 million yuan [2] - Taiping Bird reported a Q3 net loss of 49.45 million yuan [2] - COFCO Technology reported a Q3 net loss of 28.06 million yuan [2]

智通财经APP讯，天臣医疗(688013.SH)披露2025年第三季度报告，公司前三季度实现营收2.44亿元，同 比增长20.66%;归属于上市公司股东的净利润7195万元，同比增长68.29%;扣非净利润6620万元，同比增 长71.85%;基本每股收益0.90元。 ...

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 10月23日消息，天臣医疗发布三季度报告。 责任编辑：小浪快报 公告显示，公司前三季度营业收入243,831,328.07元，同比增加20.66%，归属上市公司股东的净利润 71,945,750.36元，同比增加68.29%。 公告显示，十大流通股东中，马敬娥、何汝豪、林纯青为新进流通股东。 ...

天臣国际医疗科技股份有限公司2025 年第三季度报告 证券代码：688013 证券简称：天臣医疗 天臣国际医疗科技股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 | | | 本报告期比 | | 年初至报告期 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期增 | 年初至报告期末 | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 87,663,076.62 | 26.40 | 243, ...

格隆汇10月23日丨天臣医疗(688013.SH)公布，公司前三季度实现营业收入2.44亿元，同比增长 20.66%；归属于上市公司股东的净利润7194.58万元，同比增长68.29%；归属于上市公司股东的扣除非 经常性损益的净利润6620.23万元，同比增长71.85%；基本每股收益0.90元。 ...

Core Insights - Tianchen Medical (688013) reported a significant increase in revenue and net profit for Q3 2025, with revenue reaching 87.66 million yuan, a year-on-year growth of 26.4% [1] - The company's net profit for Q3 was 23.73 million yuan, reflecting a substantial year-on-year increase of 70.74% [1] - For the first three quarters of 2025, Tianchen Medical achieved a total revenue of 244 million yuan, marking a year-on-year growth of 20.66% [1] - The net profit for the first three quarters was 71.95 million yuan, which is a year-on-year increase of 68.29% [1] - The basic earnings per share for the company stood at 0.9 yuan [1]

天臣医疗公告，第三季度营收为8766.31万元，同比增长26.40%；净利润为2373.42万元，同比增长 70.74%。前三季度营收为2.44亿元，同比增长20.66%；净利润为7194.58万元，同比增长68.29%。 ...

截至2025年10月10日收盘，天臣医疗(688013)报收于59.46元，下跌2.99%，换手率1.27%，成交量1.03万 手，成交额6187.05万元。 当日关注点 交易信息汇总资金流向 天臣国际医疗科技股份有限公司于2023年12月27日启动股份回购，原定实施期限至2024年12月26日，后 经调整延长至2025年12月26日。回购资金总额由最初1,800万元至3,600万元逐步上调至4,600万元至8,000 万元，资金来源包括公司自有资金及不超过3,465万元的中信银行专项贷款。回购股份拟用于员工持股 计划或股权激励。截至2025年9月30日，公司累计回购股份2,505,324股，占总股本的3.09%，已支付金 额约4,249.89万元，回购价格区间为11.87元/股至21.00元/股。2025年9月未进行回购交易。相关回购行 为符合法规及方案规定。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 来自交易信息汇总：10月10日主力资金净流入699.71万元，占总成交额11.31%。 来自公司公告汇总：天臣医疗股份回购累 ...